Potential Role of Ozenoxacin 1% Cream in the Topical Management of Hidradenitis Suppurativa: A Single-centre Experience (44 patients)
DOI:
https://doi.org/10.2340/actadv.v105.43629Keywords:
ozenoxacin, Hidradenitis Suppurativa, topical therapyDownloads
References
Zouboulis CC, Bechara FG, Benhadou F, Bettoli V, Bukvić Mokos Z, Del Marmol V, et al. European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment. J Eur Acad Dermatol Venereol 2025; 39: 899–941. DOI: https://doi.org/10.1111/jdv.20472
Matusiak Ł, Bieniek A, Szepietowski JC. Bacteriology of hidradenitis suppurativa: which antibiotics are the treatment of choice? Acta Derm Venereol 2014; 94: 699–702. DOI: https://doi.org/10.2340/00015555-1841
Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol 1983; 22: 325–328. DOI: https://doi.org/10.1111/j.1365-4362.1983.tb02150.x
Gulliver W, Zouboulis CC, Prens E, Jemec GB, Tzellos T. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord 2016; 17: 343–351. DOI: https://doi.org/10.1007/s11154-016-9328-5
Schachner LA, Lynde CW, Kircik LH, Torrelo A, Hohl D, Kwong P, et al. Treatment of impetigo and antimicrobial resistance. J Drugs Dermatol 2021; 20: 366–372. DOI: https://doi.org/10.36849/JDD.5795
Published
How to Cite
License
Copyright (c) 2025 Pablo Fernández-Crehuet, Delia Diaz-Ceca, F. Javier Melgosa Ramos
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
